MedTrace Logo

Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs

NCT05350930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2025-03-07

No results posted yet for this study

Summary

Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, reduction of Drug-Related Problems (DRPs), and re-hospitalizations.

This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare

Conditions

  • Chemotherapy Effect
  • G-CHOP Chemotherapy
  • R-CHOP Chemotherapy

Interventions

OTHER

Assessment of patient satisfaction regarding tele-consultation

Questionnaire completed following the teleconsultation, if applicable.

OTHER

Literacy questionnaire

Questionnaire completed during hospitalization for the first chemotherapy cycle

OTHER

Collection of socio-demographic characteristics

Questionnaire completed during patient hospitalization for the first chemotherapy cycle

OTHER

Assessment of patient knowledge on chemotherapy side effects and support medications

Questionnaire completed during patient hospitalization for the first, second and sixth cycle of chemotherapy

OTHER

Assessment of patient satisfaction on pharmaceutical follow-up

Questionnaire completed during patient hospitalization for the sixth chemotherapy cycle

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-09
Primary Completion
2023-02-15
Completion
2023-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350930 on ClinicalTrials.gov